Suppression of immune responses to sheep erythrocytes by the lymphokine soluble immune response suppressor (SIRS) in vivo.
Authors:
Open Access
- 1 August 1986
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 137 (3) , 863-867
Abstract
Soluble immune response suppressor (SIRS) is a protein produced by activated suppressor T lymphocytes which inhibits division by tumor cells and plaque-forming cell (PFC) responses in vitro. Although this lymphokine has been fairly well characterized in vitro, little is known about its effects in vivo. Purified murine SIRS, 10(3) to 10(4) U injected i.p., suppressed murine PFC responses to sheep erythrocytes (SRBC) in vivo. Suppression occurred when SIRS was injected into mice 5 days before assay, and also occurred when SIRS activated with 10(-6) M H2O2 was injected 24 hr before assay. These kinetics are similar to those observed in tissue culture, where suppression of PFC responses requires the addition of SIRS 4 to 5 days before assay unless SIRS is activated to SIRSox by H2O2. Levamisole, an inhibitor of SIRS-mediated suppression in vitro, also blocked suppression by SIRS in vivo. Delayed-type hypersensitivity reaction to footpad injection of SRBC was also inhibited by SIRS. Suppression of PFC responses by recombinant immune interferon (IFN-gamma), which activates lymphocytes to produce SIRS in vitro, was blocked by injection of levamisole or monoclonal anti-SIRS antibodies. These results show that SIRS suppresses immune responses in vivo, and suggest that suppression of PFC responses by IFN-gamma may be largely mediated by SIRS. These findings indicate that SIRS could contribute to the development of suppressed immunity in vivo.Keywords
This publication has 13 references indexed in Scilit:
- Identification of the lymphokine soluble immune response suppressor in urine of nephrotic children.Journal of Clinical Investigation, 1985
- Two different pathways of interferon mediated suppression of antibody secretionInternational Journal of Immunopharmacology, 1985
- Soluble immune response suppressor (SIRS) inhibits microtubule function in vivo and microtubule assembly in vitro.The Journal of Immunology, 1984
- Identification and initial characterization of concanavalin A- and interferon-induced human suppressor factors: evidence for a human equivalent of murine soluble immune response suppressor (SIRS).The Journal of Immunology, 1984
- Interleukin 2 administered in vivo induces the growth of cultured T cells in vivo.The Journal of Immunology, 1984
- Suppressor T cell activation by human leukocyte interferon.The Journal of Immunology, 1983
- Inhibition of interferon or soluble immune response suppressor (SIRS) mediated suppression by levamisoleInternational Journal of Immunopharmacology, 1983
- Interferon-mediated inhibition of human polyclonal immunoglobulin synthesis.The Journal of Immunology, 1982
- Activation of a suppressor T-cell pathway by interferon.Proceedings of the National Academy of Sciences, 1982
- Conversion of soluble immune response suppressor to macrophage-derived suppressor factor by peroxide.Proceedings of the National Academy of Sciences, 1981